Weiss Asset Management’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-100,000
Closed -$1.02M 377
2023
Q1
$1.02M Sell
100,000
-1,005
-1% -$10.2K 0.07% 178
2022
Q4
$1.02M Hold
101,005
0.04% 298
2022
Q3
$996K Buy
+101,005
New +$991K 0.02% 466

Weiss Asset Management's ORIA Position: Q2 2023 in Review

Weiss Asset Management sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 100,000 shares — an estimated $1.02M sold.

Weiss Asset Management first reported a position in ORIA in Q3 2022 and held it in 3 quarters. The position peaked at $1.02M in Q1 2023. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

  • Weiss Asset Management reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
  • Weiss Asset Management sold 100,000 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.02M.
  • Weiss Asset Management first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2022 and held it in 3 quarters.
  • Weiss Asset Management's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.02M in Q1 2023.
  • 0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on Weiss Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.